Ambalal Sarabhai Enterprises Ltd., established in 1978, is a pioneering Indian pharmaceutical company with diverse operations, including pharmaceuticals and electronics. The company is known for its strategic technology partnerships and collaborations, both domestically and internationally, enhancing its capability to produce and market a wide array of products. In the pharmaceuticals segment, it manufactures drugs and formulations, while its electronics segment focuses on producing electronic instruments and associated services.
Over the years, Ambalal Sarabhai has formed significant alliances and joint ventures, such as with Biobras, Brazil, for insulin production, and with B V Chiron, Netherlands, and Chiron Corporation, USA, for anti-cancer drugs. Notable acquisitions include Suvik Hitek Pvt. Ltd. and Systronics (India) Pvt. Ltd. The company also established Vovanties Laboratories for specialized drug delivery systems and Sarabhai M Chemicals Ltd for Vitamin C products. Recently, its subsidiary Asence Pharma Pvt. Ltd. launched a new oncology and synthetic API plant in Vadodara.
